Chibon, Frédéric <br/><br/>
Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations.  [electronic resource] 

 -  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc  Mar 2009 
 - 403-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-0285 
<br/><br/><label>Standard No.: </label>10.1038/modpathol.2008.195  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>Chromosomes, Human, Pair 17--genetics<br/>Female<br/>Gene Amplification<br/>Gene Dosage<br/>Genes, erbB-2<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization<br/>Practice Guidelines as Topic<br/>Receptor, ErbB-2--biosynthesis<br/>United States<br/>United States Food and Drug Administration